Emery-Dreifuss muscular dystrophy: genes and variants
Explore variant evidence for Emery-Dreifuss muscular dystrophy across 3 analyzed proteins (LMNA, TMEM43, FHL1). Linked ClinVar records include 12 pathogenic or likely pathogenic variants, 65 variants of uncertain significance and 38 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Emery-Dreifuss muscular dystrophy
LMNA: Prelamin-A/C
The gene product produces lamins A and C, structural proteins that form the nuclear lamina beneath the inner nuclear membrane. Lamins help maintain nuclear shape and organize chromatin, and LMNA variants are associated with muscular dystrophy, cardiomyopathy, lipodystrophy, and premature-aging syndromes.
12 ClinVar pathogenic / likely pathogenic and 71 uncertain variants in LMNA have source records linked to Emery-Dreifuss muscular dystrophy. Association strength is not clinical gene validity.
TMEM43: Transmembrane protein 43
A multi-pass membrane protein that helps organize protein complexes at the inner nuclear membrane and retain emerin. It also participates in innate-immune signaling and contributes to electrical coupling in the inner ear, with variants linked to cardiomyopathy and auditory neuropathy.
0 ClinVar pathogenic / likely pathogenic and 31 uncertain variants in TMEM43 have source records linked to Emery-Dreifuss muscular dystrophy. Association strength is not clinical gene validity.
FHL1: Four and a half LIM domains protein 1
It organizes protein complexes in striated muscle and participates in mechanosensing, sarcomere structure, and transcriptional responses. X-linked pathogenic variants cause a spectrum including reducing-body myopathy, Emery-Dreifuss muscular dystrophy, scapuloperoneal myopathy, and cardiomyopathy.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in FHL1 have source records linked to Emery-Dreifuss muscular dystrophy. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): ESR1.
ClinVar pathogenic and likely pathogenic variants linked to Emery-Dreifuss muscular dystrophy
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| LMNA R377C | 377 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R296C | 296 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R349W | 349 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R28Q | 28 | Head | Pathogenic / likely pathogenic (★★) |
| LMNA G232E | 232 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R249G | 249 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R386K | 386 | IF rod | Pathogenic / likely pathogenic (★★) |
| LMNA R453P | 453 | LTD | Pathogenic / likely pathogenic (★★) |
| LMNA W514R | 514 | LTD | Pathogenic / likely pathogenic (★★) |
| LMNA N56K | 56 | IF rod | Pathogenic / likely pathogenic (★) |
| LMNA Q462P | 462 | LTD | Pathogenic / likely pathogenic (★) |
| LMNA L530P | 530 | LTD | Pathogenic / likely pathogenic |
Which prediction tools work for Emery-Dreifuss muscular dystrophy
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- MetaLR: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- CATVariant: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 98 out of 100
- MetaSVM: 98 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- ESM1b (LLR): 96 out of 100
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 89 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 81 out of 100
Same protein, different disease
- Charcot-Marie-Tooth disease also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Emery-Dreifuss muscular dystrophy variants (130 pathogenic / likely pathogenic).
- Dilated cardiomyopathy also has ClinVar records linked to LMNA variants; they fall mostly in different places as the Emery-Dreifuss muscular dystrophy variants (21 pathogenic / likely pathogenic).
- Familial partial lipodystrophy, Dunnigan type also has ClinVar records linked to LMNA variants; they fall partly in the same places as the Emery-Dreifuss muscular dystrophy variants (13 pathogenic / likely pathogenic).
- Muscular dystrophy due to LMNA mutation also has ClinVar records linked to LMNA variants; they fall partly in the same places as the Emery-Dreifuss muscular dystrophy variants (11 pathogenic / likely pathogenic).
- Hutchinson-Gilford syndrome also has ClinVar records linked to LMNA variants; they fall partly in the same places as the Emery-Dreifuss muscular dystrophy variants (9 pathogenic / likely pathogenic).
Diseases related to Emery-Dreifuss muscular dystrophy
- Arrhythmogenic right ventricular dysplasia, also linked to LMNA and TMEM43
- Charcot-Marie-Tooth disease, also linked to LMNA
- Dilated cardiomyopathy, also linked to LMNA
- Bethlem myopathy, also linked to LMNA
- Limb-girdle muscular dystrophy, also linked to LMNA
- Primary dilated cardiomyopathy, also linked to LMNA
- Auditory neuropathy, also linked to TMEM43
- X-linked myopathy with postural muscle atrophy, also linked to FHL1
- Familial partial lipodystrophy, Dunnigan type, also linked to LMNA
- Muscular dystrophy due to LMNA mutation, also linked to LMNA
- Muscular dystrophy, also linked to LMNA
- Hutchinson-Gilford syndrome, also linked to LMNA
Frequently asked questions
Which genes have records linked to Emery-Dreifuss muscular dystrophy?
This view contains 3 analyzed proteins: LMNA, TMEM43, FHL1. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 12 pathogenic or likely pathogenic variants, 65 variants of uncertain significance and 38 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 175 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center